GENZYME CORP Financing Cash Flow
GENZYME CORP reported Financing Cash Flow of $220.92 million for the 12-month period ending 2010-12-31, per its 10-K filed 2011-03-01.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2011-03-01
- GENZYME CORP net cash provided by (used in) financing activities for the quarter ending 2010-12-31 was $119.64M, a 351.10% increase year-over-year.
- GENZYME CORP net cash provided by (used in) financing activities for the quarter ending 2010-09-30 was $95.00M.
- GENZYME CORP net cash provided by (used in) financing activities for the quarter ending 2010-06-30 was $31.99M, a 254.82% increase year-over-year.
- GENZYME CORP net cash provided by (used in) financing activities for the quarter ending 2010-03-31 was -$25.71M.
- GENZYME CORP net cash provided by (used in) financing activities for fiscal 2010 was $220.92M.
- GENZYME CORP net cash provided by (used in) financing activities for fiscal 2009 was -$336.62M.
- GENZYME CORP net cash provided by (used in) financing activities for fiscal 2008 was -$466.24M.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2010-12-31 | $119.64M derived: 10-K 12 month − 10-Q 9 month · filed 2011-03-01 | $214.64M derived: sum of 2 quarters · filed 2011-03-01 | $246.63M derived: sum of 3 quarters · filed 2011-03-01 | $220.92M 10-K · filed 2011-03-01 |
| 2010-09-30 | $95.00M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2010-11-09 | $127.00M derived: sum of 2 quarters · filed 2010-11-09 | $101.29M 10-Q · filed 2010-11-09 | $127.81M derived: sum of 4 quarters · filed 2011-03-01 |
| 2010-06-30 | $31.99M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2010-09-07 | $6.28M 10-Q/A · filed 2010-09-07 | $32.80M derived: sum of 3 quarters · filed 2011-03-01 | -$266.18M derived: sum of 4 quarters · filed 2011-03-01 |
| 2010-03-31 | -$25.71M 10-Q/A · filed 2010-05-11 | $812.00K derived: sum of 2 quarters · filed 2011-03-01 | -$298.18M derived: sum of 3 quarters · filed 2011-03-01 | -$289.16M derived: sum of 4 quarters · filed 2011-03-01 |
| 2009-12-31 | $26.52M derived: 10-K 12 month − 10-Q 9 month · filed 2011-03-01 | -$272.47M derived: sum of 2 quarters · filed 2011-03-01 | -$263.45M derived: sum of 3 quarters · filed 2011-03-01 | -$336.62M 10-K · filed 2011-03-01 |
| 2009-09-30 | -$298.99M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2010-11-09 | -$289.97M derived: sum of 2 quarters · filed 2010-11-09 | -$363.14M 10-Q · filed 2010-11-09 | -$1.02B derived: sum of 4 quarters · filed 2011-03-01 |
| 2009-06-30 | $9.02M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2010-09-07 | -$64.15M 10-Q/A · filed 2010-09-07 | -$717.92M derived: sum of 3 quarters · filed 2011-03-01 | -$551.26M derived: sum of 4 quarters · filed 2011-03-01 |
| 2009-03-31 | -$73.17M 10-Q/A · filed 2010-05-11 | -$726.93M derived: sum of 2 quarters · filed 2011-03-01 | -$560.28M derived: sum of 3 quarters · filed 2011-03-01 | |
| 2008-12-31 | -$653.77M derived: 10-K 12 month − 10-Q 9 month · filed 2011-03-01 | -$487.11M derived: sum of 2 quarters · filed 2011-03-01 | -$466.24M 10-K · filed 2011-03-01 | |
| 2008-09-30 | $166.65M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2009-11-02 | $187.52M 10-Q · filed 2009-11-02 | ||
| 2008-06-30 | $20.87M 10-Q/A · filed 2009-09-04 | |||
| 2007-12-31 | $64.62M 8-K · filed 2010-06-14 |